Lenvatinib
Lenvatinib is a multi-target inhibitor, mostly for VEGFR2(KDR)/VEGFR3(Flt-4) with IC50 of 4 nM/5.2 nM, less potent against VEGFR1/Flt-1, ~10-fold more selective for VEGFR2/3 against FGFR1, PDGFRα/β in cell-free assays. Lenvatinib (E7080) also inhibits FGFR1-4, PDGFR, Kit (c-Kit), RET (c-RET), and shows potent antitumor activities. Phase 3.
| Trivial name | E7080 |
| Catalog Number | S1164 |
| Molecular Formula | C21H19ClN4O4 |
| CAS# | 417716-92-8 |
| Inchi | InChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28) |
| Inchi Key | WOSKHXYHFSIKNG-UHFFFAOYSA-N |
| SMILES | COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl |
| Size | 50mg |
| Supplier Page | http://www.selleckchem.com/products/E7080.html |
| Additional Information | https://file.selleck.cn/downloads/struct/E7080-chemical-structure-S1164.gif |